LINX Reflux Management System in Subjects With GERD Who Have Previously Undergone a Laparoscopic Sleeve Gastrectomy

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 5, 2017

Primary Completion Date

June 8, 2021

Study Completion Date

June 8, 2021

Conditions
GERDGastroesophageal Reflux Disease
Interventions
DEVICE

LINX device

The LINX device is a permanent implant placed at the area of the lower esophageal sphincter (LES) and is designed to augment a weak LES and minimize or eliminate GERD-related symptoms.

Trial Locations (12)

12983

Adirondack Surgical Group, Saranac Lake

14203

Buffalo General Medical Center, Buffalo

27834

East Carolina University, Greenville

29485

Coastal Carolina Bariatric & Surgical Center, Summerville

44106

University Hospitals Cleveland Medical Center, Cleveland

54601

Gunderson Health System, La Crosse

72758

Mercy Health Northwest Arkansas, Rogers

79106

Panhandle Weight Loss Center, Amarillo

80113

Institute of Esophageal and Reflux Surgery, Englewood

85741

Northwest Allied Bariatric & Foregut Surgery, Tucson

90033

Keck Medical Center of USC, Los Angeles

08873

RWJBH Univ. Hospital Somerset/Advanced Surgical and Bariatrics of NJ, PA, Somerset

All Listed Sponsors
lead

Torax Medical Incorporated

INDUSTRY

NCT02429830 - LINX Reflux Management System in Subjects With GERD Who Have Previously Undergone a Laparoscopic Sleeve Gastrectomy | Biotech Hunter | Biotech Hunter